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MMR vaccine uptake may be lower than reported because of
manipulation of target groups
Editor—One issue seems to have been
completely ignored in the current debate on
vaccination against measles, mumps, and
rubella (MMR). The average uptake of the
MMR vaccine across England now stands
officially at 84%, some way off the recom›
mended target of 95%. Although this rate is
of considerable concern in itself, vaccine
uptake may be even lower than reported.
Falling rates of vaccine uptake and the
subsequent loss of income experienced by
several general practices failing to reach
payment targets have prompted some
general practitioners to take unusual meas›
ures. They have temporarily removed chil›
dren whose parents object to vaccination
with MMR vaccine from their lists immedi›
ately before they would have been included
in the target group for vaccination. These
children are therefore excluded from the
denominator for calculating vaccine uptake.
The general practitioners concerned write
to parents informing them of the “tempo›
rary measure” and undertake to provide all
usual services to these children at no cost.
The immediate result is that vaccine uptake
appears artificially high and general practi›
tioners receive payment for reaching vac›
cine targets. After the payment deadline is
passed the patients are accepted back on to
the list.
As a result of this manipulation of
vaccine coverage the population may be at
even greater risk of a measles outbreak than
has been previously supposed. Further›
more, because these patients are not
registered, capitation payments to primary
care trusts may be reduced leading to a loss
of health care for local people. Such action
continues in this health authority area,
despite strong advice against it from the
Department of Health, the health authority,
and the local medical committee. The
General Medical Council has written that as
long these patients are treated on the same
footing as other NHS patients, the doctors’
conduct will not give rise to ethical
objections from the council. Thus general
practitioners engaged in this practice see no
reason to stop.
Although the Department of Health
may be correct in its decision to persevere
with the MMR vaccine, it is time to review
how vaccine target payments are calculated.
The Department of Health could consider
practices that pool risk. One partner in a
practice could carry the financial burden of
patients who decline vaccination: currently
targets are calculated for the practice. The
department could consider accepting a writ›
ten disclaimer from patients as acceptance
that a practice has made every effort to vac›
cinate the children concerned.
While the current doubts about MMR
vaccine, however unfounded, continue, this
manipulation of target figures is likely to
increase, leading to more uncertainty about
the accuracy of vaccine coverage, and in
effect placing the population at greater risk.
Thomas J Scanlon consultant in public health
medicine
East Sussex, Brighton and Hove Health Authority,
Lewes, East Sussex BN7 2PB
toms@esbhhealth.cix.co.uk
MMR vaccine debate
Debate crystallises dilemma facing many
medical disciplines
Editor—Tom Heller articulates the
dilemma facing doctors in many medical
disciplines in his article in the ethical debate
on measles, mumps, and rubella (MMR) vac›
cine, a debate that is being stifled because of
the overwhelming evidence base in favour of
immunisation.1 He reaches the core of the
debate when he refers to the balance to be
struck between informed consent and the
right of the state to control an infectious dis›
ease. He may feel uncomfortable because he
is caught between two roles: that of the agent
of the state, which doctors are often
unwittingly asked to be, and that of protect›
ing the best interest of his patients.
After Alder Hey and Bristol a lot of
noise has been made centrally about the
need to put patients first and reverse what is
seen as the historical imbalance in power
between doctors and clients, as Pattison
points out in the final paragraph of his con›
tribution to the debate.1 The need for a
power differential between experts and
clients and for an implicit contract between
the parties in terms of who delivers the
expertise is currently out of vogue.
If the profession is to be shaken into
putting patients first, how does it also put
evidence or central government directives
first? Doing it surreptitiously by payments
for immunisation targets helps no one.
Therefore, in its attempt to put patients first
the government will presumably now revoke
immunisation targets and reincorporate the
monies into general practitioners’ basic
remuneration—still time to include this in
the new contractual arrangements.
If not, then it will presumably support
giving doctors time to prepare their own
leaflets on the available evidence, individual›
ise their patient care, and then state that
once informed it is entirely up to parents to
decide on the best course of action for their
child.
The only other way to extract clinicians
from this mire would be to separate the
functions of patient advocacy and protec›
tion from central pronouncements and
evidence based medicine. This might lead to
the evolution of new professions: those of
expert (remunerated) patient advocates
accompanying patients to consultations. It
could also lead to two types of doctors: those
trained in evidence based medicine and
those trained in person centred medicine.
They would work in pairs and debate issues
in front of patients, who would then decide.
This already happens in the postmodern
world of family therapy, in the “reflecting
team” approach.2 It would cost more, but it
might allow people to reoccupy positions of
expertise that are reconcilable and put
patients where the government wants them:
in the driving seat. Of course they might
have to take responsibility for their deci›
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sions, and what would that do to the system
in which people sue for negligence?
Richard Fry child and family psychiatrist
Child Family and Adolescent Consultation Service,
Uxbridge, Middlesex, UB8 1BN
Richard.Fry@hhh›tr.nthames.nhs.uk
Competing interests: None declared.
1 Heller T, Heller D, Pattison S, Heller T. Ethical debate: Vac›
cination against mumps, measles, and rubella: is there a
case for deepening the debate? BMJ 2001;323:838›40. (13
October.)
2 Andersen T. The reflecting team: dialogue and meta›
dialogue in clinical work. Family Process 1987;26:415›28.
General practitioners’ two roles are not in
conflict with MMR immunisation
Editor—I am intrigued by Fry’s statement
in his electronic response to the ethical
debate on measles, mumps, and rubella
(MMR) vaccine (letter printed above) that
general practitioners are caught between
being agents of the state and protecting the
best interests of their patients.1 2 To my mind,
at least when it comes to immunisation
against measles, mumps, and rubella, there is
no problem at all: by encouraging MMR
immunisation, doctors are protecting the
best interests of their patients. The patient in
front of the general practitioner may be
more likely to benefit than be harmed by the
vaccination.
In addition, the population benefits are
notable. Because measles is so infectious, a
high uptake of MMR vaccine is necessary to
maintain herd immunity. If rates drop to, say,
60%, then herd immunity will be lost, and
nearly all of the vulnerable 40% will get
measles. There are over 600 000 births per
year, so about 240 000 children would get
measles each year, and, taking Dick Heller’s
more conservative figure,2 we should conse›
quently expect to see 240 deaths.
Peter M B English consultant in communicable
disease control
Surrey Communicable Disease Control Service,
East Surrey Health Authority, Epsom, Surrey
KT19 8PH
peter_english@bigfoot.com
Competing interests: None declared.
1 Fry R. MMR: Caught betweeen stools. Electronic response
to Ethical debate: Vaccination against mumps, measles,
and rubella: is there a case for deepening the debate?
bmj.com 2001 (www.bmj.com/cgi/eletters/323/7317/
838#16953; accessed 13 March 2002.)
2 Heller T, Heller D, Pattison S, Heller T. Ethical debate: vac›
cination against mumps, measles, and rubella: is there a
case for deepening the debate? BMJ 2001;323:838›40. (13
October.)
Single measles vaccine should be allowed
Editor—The controversy surrounding
measles, mumps, and rubella (MMR) vaccine
will not go away. The title of the series of
articles poses the question whether there is a
case for deepening the debate.1 I believe that
there is. Many of us are not in a position to
evaluate critically all the evidence presented
and are further confused to find that well
qualified experts stand in both camps of the
debate.
From the infant’s perspective, immunisa›
tion against measles seems the most
pressing as infection carries a small risk of
serious and even fatal complications.
Mumps and rubella are far less serious for
infants, and my understanding is that the
only scientific argument for immunising
infants against these two diseases is to estab›
lish a good herd immunity, which will
benefit society and reduce infections of non›
immune older children and adults, in whom
sequelae of mumps and rubella can be more
serious. I can also see the practical and eco›
nomic reason for providing an immunisa›
tion against more than one disease in a
single vaccine. But should the benefit to
society take precedence over possible risks
to an individual? My understanding of
Wakefield’s hypothesis is that in a very small
number of children the triple vaccine may
precipitate Crohn’s disease or autism.2
What I find puzzling is the adamant
refusal of the authorities to facilitate the
availability of the single measles vaccine, to
the point that the Department of Health has
banned its use in the NHS. How does this fit
with the growing acceptance of patients’
autonomy and choice? It is now enshrined
in case law that a pregnant women can, for
rational or irrational reasons, refuse treat›
ment even if that refusal fatally jeopardises
her unborn child.
The medical profession should support
a parent’s wish to be given single vaccines,
however irrational the establishment might
view that wish. There are some parents who
are opposed to the rubella component of
MMR, because of its manufacture on cell
lines extracted from aborted fetuses, but
who would still wish their child to be immu›
nised using single vaccines available in other
countries. The arguments against use of sin›
gle vaccines on grounds of safety and
efficacy are weak and difficult to accept, par›
ticularly when other countries with equival›
ent medical and ethical standards make
them freely available.
Michael Jarmulowicz master, Guild of Catholic
Doctors
Royal Free Hospital, London NW3 2QG
Michael.Jarmulowicz@rfh.nthames.nhs.uk
Competing interests: None declared.
1 Heller T, Heller D, Pattison S, Heller T. Ethical debate: Vac›
cination against mumps, measles, and rubella: is there a
case for deepening the debate? BMJ 2001;323:838›40. (13
October.)
2 Wakefield A, Murch S, Anthony A, Linnell J, Casson D,
Malik M, et al. Ileal›lymphoid nodular hyperplasia,
non›specific colitis, and pervasive developmental disease
in children. Lancet 1998;351:1327›18.
There is no room for lingering doubt
Editor—We write to commend and com›
plain, with reference to the debate on the
safety of measles, mumps, and rubella
(MMR) vaccine from a primary care
perspective.1 Ethical debate is a central part
of the jigsaw of developing patient care and
may serve as the patient’s (in)visible advo›
cate. But we question the wisdom, not in
commissioning the debate, but in publishing
the anecdotal response of Heller, who has
lingering doubts about the safety of this vac›
cine. Such a reply risks indoctrinating some
parents as the final word on the subject.
In paediatrics and primary care the
uphill battle to increase vaccine uptake
seems to get increasingly difficult. Countless,
perhaps excessive, hours are currently
expended in both primary and secondary
care counselling parents about the safety of
the vaccine. This is not because they are
awkward, ignorant, or ambiguous, more
because they are becoming more
“informed.” Some of their information
comes from the popular press or online
information sources, including the well
known flawed research by Wakefield et al.2
Furthermore, the BMJ is one of the most
frequently quoted in the popular press and
available to all online.
The list of professional groups that
endorse the vaccine is exhaustive.3 Why then
publish alongside it at best anecdotal
evidence from one general practitioner that
he has lingering doubts about the safety of
the vaccine? This adds nothing constructive
in the way of ethical debate and only serves
to scaremonger.
Informed refusal must remain an
acceptable choice, but the overwhelming
evidence currently available is that the
vaccine is safe. Until there is evidence to the
contrary we in the medical profession must
unite and encourage vaccine uptake. It is not
a case of keeping one’s head down, simply
good practice. The Children Act 1989 high›
lights parental responsibility. We as health›
care providers would do well to follow this
dogma in the setting of MMR vaccination.
We have a responsibility to endorse it
emphatically; any less is a failure and a
breach of our terms of service, visible or
invisible.
The personal view by Morris tucked
away towards the back of the same edition
painted the darker side of measles in the
context of subacute sclerosing panencepha›
litis.4 Honest yes, scaremongering no. In the
setting of MMR vaccine, we need more of
this and less of the lingering doubt.
Nick Barnes specialist registrar, paediatrics
Royal Berkshire Hospital, Reading RG1 5AN
nickbarnes10@hotmail.com
Elizabeth James general practitioner
Didcot Health Centre, Didcot OX11 7JN
Competing interests: None declared.
1 Heller T, Heller D, Pattison S, Heller T. Ethical debate: Vac›
cination against mumps, measles, and rubella: is there a
case for deepening the debate? BMJ 2001;323:838›40. (13
October.)
2 Wakefield A, Murch S, Anthony A, Linnell J, Casson D,
Malik M, et al. Ileal›lymphoid nodular hyperplasia,
non›specific colitis, and pervasive developmental disease
in children. Lancet 1998;351:1327›18.
3 CSM/MCA. Current problems in pharmacovigilance
2001;27:3.
4 Morrison L. Measles—a minor childhood illness? BMJ
2001;323:875. (13 October.)
Competing interests need to be declared
Editor—Tom Heller asks what we are to
make of researchers who declare funding
from drug manufacturers involved in manu›
facturing vaccines.1 He and others deserve a
general answer as there is a danger that such
declarations may be being misunderstood.
Virtually all new vaccines in use in
developed countries today are made by
commercial companies. These vaccines have
to be put through clinical trials (usually in
children) to demonstrate safety and efficacy
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before licensure, the costs of which are paid
for by the manufacturers. Such studies are
done by doctors, and it is desirable that these
doctors should be independent rather than
employees of the companies. Thus their
aims should be to conduct only scientifically
sound studies and protect the subjects
enrolled, rather than make a profit for the
company. It is therefore standard practice
that agreements between such researchers
and sponsoring companies exclude the
researchers from personal financial gain—
for example, through investment in the
sponsoring company.
Nevertheless, a result of this system is
that virtually all clinical research studies on
new drugs and vaccines coming to licensure
are commercially funded. The professional
success of clinical researchers depends prin›
cipally on the research income they can
generate. Thus researchers—although they
are usually not receiving personal financial
inducements—have a competing interest,
which they correctly declare.
Readers should interpret such declara›
tions as a qualification to give a well
informed opinion, as anyone unable to
declare such competing interests is unlikely
ever to have had any direct experience of
using new vaccines in children. The main
advantage of the system is, however, that it
promotes transparency. Clinical researchers
(and editors) are leading the way here, and
other authors should start to consider how
they too can declare the interests and
motives that underlie the opinions they
express in public.
Adam Finn professor of paediatrics
Institute of Child Health, University of Bristol,
Bristol BS2 8DJ
Adam.Finn@bristol.ac.uk
Competing interests: AF has received substantial
funding for research and academic activities from
virtually all vaccine manufacturers during the past
five years. He has received no personal income from
such sources.
1 Heller T, Heller D, Pattison S, Heller T. Ethical debate: Vac›
cination against mumps, measles, and rubella: is there a
case for deepening the debate? BMJ 2001;323:838›40. (13
October.)
Authors’ summary of responses
Editor—Our ethical debate on measles
mumps, and rubella (MMR) vaccine gener›
ated responses sent to us individually as well
as rapid responses posted to bmj.com. We
received 14 personal responses by email
(and a further four responses from journal›
ists, which are not considered further) and
17 public rapid responses were published by
February 2001 (two further responses were
posted after preparing this report). Nine of
the 14 personal respondents and 10 of the
17 public respondents replied to our email
request for further information.
Personal respondents were less likely
than public respondents to be health
professionals. Nine personal respondents
mentioned MMR vaccine or autism in their
family and seven declared an anti›MMR
stance (table). Some commented positively
on our courage (particularly that of
TH)—for example, “There are too few
people who are prepared to speak out and I
thought you should know that there are
others out there who feel deeply about the
issue” and “Thank you for voicing your con›
cerns about MMR. It is refreshing to see a
member of the medical profession voice a
valid concern.”
Among the nine personal respondents
who sent further information, four had pre›
viously responded to articles in the BMJ
(compared with seven of the 10 public
respondents) and six stated that a personal
or professional interest had motivated their
response (compared with four of the public
respondents). Reasons for sending a per›
sonal response to us included a greater like›
lihood of getting a reply (four respondents)
and a preference for private, direct discus›
sion (three). Most of the public respondents
wanted to join the debate and to seek a
wider audience for this. None of the
personal respondents made the point that
herd immunity is important and that ethics
discussions should balance individual and
public responsibility.1
Although the rapid response option on
bmj.com offers the opportunity to join the
debate on contentious issues such as MMR
vaccine, it does not capture the responses of
a small but important readership of the
original publication. Those who responded
to us personally seemed to share many of
the public’s concerns about, and perspec›
tives on, MMR vaccination.2 3 Examining the
views of those who respond in different ways
to journal articles may offer insights into
health controversies. Medical journals and
health policymakers might wish to explore
the ways of doing this.
Dick Heller professor of public health
Evidence for Population Health Unit, School of
Epidemiology and Health Sciences, University of
Manchester Medical School, Manchester M13 9PT
Tom Heller senior lecturer
School of Health and Social Welfare, Open
University, Milton Keynes MK7 6AA
Stephen Pattison head
Department of Religious and Theological Studies,
University of Cardiff, Cardiff CF10 3EU
Competing interests: None declared.
1 Health experts support MMR vaccine. Available at www.
ephu.man.ac.uk/GrandRounds/2001_11/
MMRPressRelease.htm
2 Jewell D. MMR and the age of unreason. Br J Gen Pract
2001;51:875›6.
3 Evans M, Stoddart H, Condon L, Freeman E, Gizzell M,
Mullen R. Parents’ perspectives on the MMR immunisa›
tion: a focus group study. Br J Gen Pract 2001;51:904›10.
Physician assistants
Many general practitioners would
welcome having physician assistants
Editor—The possibility of creating an
American style, intermediate medical prac›
titioner or physician assistant role has been
too long ignored in debates about shortages
of trained medical staff in the NHS. In
casting doubt on the appropriateness of this
particular approach, however, Hutchinson
et al lamentably fail to appreciate the scale
of the problems currently faced by the NHS
in providing effective primary medical care.1
They state that more than half of all doc›
tors are general practitioners. Not so. Half of
all medical graduates may eventually finish
their careers as general practitioners—an
artefact of the way the medical labour
market is organised—but general practition›
ers currently make up about 31% of all doc›
tors.2 The number as a proportion of the
medical workforce has been falling for years;
and research examining the career prefer›
ences of junior doctors suggests that the dif›
ficulties may soon get worse.3
Problems of recruitment in general
practice, as the authors observe, are particu›
larly acute in inner cities, which have never
had much “doctor appeal.” The backbone of
the medical labour force in such neighbour›
hoods has come from the ranks of doctors
who qualified in south Asia. More than 60%
of this group will shortly reach retirement
age. Who will replace them?4
The government’s current strategies
aimed at addressing the undersupply of
general practitioners, such as increasing
places at medical school and offering
doctors cash, either to enter general practice
or delay retirement, are seriously flawed.5
Much more radical solutions are called for.
The idea of physician assistants is a radical
one, and it is time it was given serious
consideration. It certainly deserves to be
piloted and evaluated.
Recruitment of general practitioners is
at crisis point. The creation of physician
assistants could help reverse this situation. It
would be a great shame if rhetoric about the
Characteristics of respondents and responses to ethical debate on vaccination against measles, mumps,
and rubella (MMR)
Personal response to authors
(n=14)
Public electronic response to
bmj.com (n=17)
Respondent
Health professional 5 14
Personal experience of MMR or autism in family 9 0
Professional experience of MMR or autism 0 3
Declared anti›MMR stance 7 0
Response (type of comment)
Personal positive comments to authors 5 0
On science 2 5
On responsibility to whole community (herd immunity) 0 4
On concerns over official cover up of adverse evidence 3 2
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need for “seamless care” and the breaking
down of professional boundaries were to
hamper efforts to establish a physician
assistant role in the NHS and get in the way
of providing effective medical care, espe›
cially among deprived populations.
The physician assistant role has been an
overwhelming success in the United States.
There is no reason why it could not be so
here, given good will and the desire to see it
succeed.5 My own research among general
practitioners clearly indicates that they
would regard physician assistants as a
welcome addition to the primary care team.
Mike Gavin research associate in primary care
Rusholme Academic Unit, School of Primary Care,
Rusholme Health Centre, Manchester M14 5NP
mike.gavin@man.ac.uk
1 Hutchinson L, Marks T, Pitillo M. The physician assistant:
would the US model meet the needs of the NHS? BMJ
2001;323:1244›7. (24 November.)
2 Review Body on Doctors’ and Dentists’ Remuneration.
Review for 2001: written evidence from the health departments
for Great Britain. London: Department of Health, 2000.
3 Lambert TW, Goldacre MJ, Edwards C, Parkhouse J.
Career preferences of doctors who qualified in the United
Kingdom in 1993 compared with those of doctors qualify›
ing in 1974, 1977, 1980, and 1983. BMJ 1996;313:19›24.
4 Taylor DH Jr, Esmail A. Retrospective analysis of census
data on general practitioners who qualified in South Asia:
who will replace them? BMJ 1999;318:306›10.
5 Gavin M, Esmail A. Solving the recruitment crisis in UK
general practice: time to consider physician assistants?
Social Policy and Adminstration (in press).
American idea of physician assistants can
be anglicised
Editor—As a physician assistant educator
from the United States completing a sabbati›
cal with a medical school in the United King›
dom and the NHS, I am well placed to
comment on Hutchinson et al’s article.1
Shaw’s concept of “two countries sepa›
rated by a common language” applies to the
United States and the United Kingdom. The
education of doctors in the United States
takes eight years from the time they leave
school to the time they graduate from medi›
cal school. The article states that the educa›
tion of physician assistants takes six years.
With few school leavers becoming physician
assistants, however, a better figure is the
average length of core professional educa›
tion for physician assistants (24›25 months)2;
this is shorter than the evolving four year
graduate entry programmes in medical
schools in the United Kingdom.
Differences in the length of programmes
reflect differences in the countries’ overall
education systems, not substantial variation
in core training for physician assistants.
American degree standards are less consist›
ent then British ones, and assessment of
experiential learning is uncommon. Educa›
tion of physician assistants is competence
based (not degree based) and accredited as
such3; this matches the NHS plan’s “skills
escalator” concept (para. 9.18).4
The authors note that physician assist›
ants neither “perform . . . tasks of other
therapists” nor “remove professional
boundaries or barriers to expanding scope
of practice.” While some physician assistants
perform such tasks (for example, rural
physician assistants can perform basic x ray
examinations in the absence of a radiogra›
pher), this is not a core function. The
authors regard this negatively; it perpetuates
a confusing blurring of new roles identified
by the NHS plan and the Royal College of
Physicians.5
Importantly, the call for a “healthcare
practitioner” (para. 9.15), analogous to
American physician assistants, addresses
one set of needs (access to primary care, jun›
ior doctor issues) whereas the “assistant
practitioners” concept addresses needs of
“other areas” (for example, shortages in the
professions allied to medicine) (para. 9.14).
A justifiable concern is that an overly
generic practitioner, simultaneously com›
bining the American physician assistant
core with multiple assistant (profession
allied to medicine) practitioner roles, might
be a dangerous “Jack of all trades, master of
none.” The concept of healthcare prac›
titioner in the United Kingdom must be
evaluated solely against needs that it is
intended to address. Physician assistants
have proved their worth and flexibility in the
United States but are not the solution to all
ills.
Simply importing an American physi›
cian assistant “package” would not be an
ideal British solution, but evidence suggests
that physician assistants can be suitably
anglicised to patients’ benefit—presumably
this is the ultimate goal.
William H Fenn professor
Western Michigan University, Kalamazoo, MI
49009, USA
fenn@wmich.edu
1 Hutchinson L, Marks T, Pittilo M. The physician assistant:
would the US model meet the needs of the NHS? BMJ
2001;323:1244›7. (24 November.)
2 American Academy of Physician Assistants. Facts at a
glance, 6 Nov 2001. Available at www.aapa.org
3 Accreditation Review Commission on Education for the
Physician Assistant. Accreditation standards for physician
assistant education. Marshfield, WI: ARC›PA, 2001.
4 Department of Health. The NHS plan: a plan for investment,
a plan for reform. London: Stationery Office, 2000.
5 Orme M, Bloom S. Hospital doctors under pressure: new roles
for the health care workforce. London: Royal College of Phy›
sicians, 1999.
European working time
directive for doctors in training
Reduction in juniors’ hours abolishes
concept of continuity of care
Editor—The gloating editorial by Pickers›
gill, the chairperson of the BMA’s Junior
Doctors Committee, convinces me that the
BMJ is now the magazine for the coffee table
of the politically active lily›livered doctors
who populate the NHS.1 The smile will be
wiped off Pickersgill’s face if ever he is
unfortunate enough to need an operation.
The reduction in junior doctors’ hours
does not satisfy trainee surgeons’ need for
operative experience and abolishes the con›
cept of continuity of care. All surgeons
(trainees and consultants) understand that a
patient deserves and requires continual care
by the same firm for the duration of his or
her admission. Pickersgill and others need
to realise that trainee doctors’ needs differ
across the specialties and that many other
professionals work long hours. It is time that
the senate of the Royal Colleges of Surgeons
said no to Europe’s directives.
David Scott›Coombes consultant endocrine surgeon
Department of Surgery, King’s College Hospital,
London SE5 9RS
David.Scott›Coombes@kcl.ac.uk
1 Pickersgill T. The European working time directive for
doctors in training. BMJ 2001;323:1266. (1 December.)
Profession needs to modernise surgical
training
Editor—To ensure better surgical training
in shorter hours1 a more structured and
focused approach must be adopted. With
the introduction of the new deal, Calman
report, and European working time direc›
tive, the time available to train a surgeon is
now reduced by more than two thirds.
Further reductions in working hours
threaten to jeopardise the effective continu›
ation of patient care and compromise train›
ing, resulting in inexperienced surgeons.
Fundamental reform must now take place to
guarantee high surgical standard.
We must separate service provision from
training and learn from the healthcare
systems in the United States and Europe,
where qualified physician assistants (profes›
sionally trained non›medical staff) are
employed routinely to share the workload
with the junior staff.
Trainers who are willing to initiate
change must give a strong, enthusiastic lead
in improving training, which has long been
unstructured, repetitive, and at times irrel›
evant to the specialty ambitions of trainees.2
The standards for surgical practice should
be clearly monitored and enforced, and fre›
quent formal independent assessment, such
as the record of in›training assessments and
assessment by the specialist advisory com›
mittees, will help. It is essential that both
trainers and trainees are assessed, with the
royal colleges encouraging all consultants to
improve their training abilities. Good train›
ers should be recognised, and bad ones
should be excluded from training pro›
grammes.
The organisation of theoretical training
(at local or regional level) should ensure that
specific topics are taught in coordinated lec›
tures or courses, when trainees from the
same deanery are free from clinical commit›
ments. During practical training, ward
rounds and outpatient clinics should be
educational. In addition, trainees must have
hands›on experience in the operating
theatre, with proper supervision, instruction,
and practice. This may be difficult to achieve
in the NHS, which is already limited in time
and resources. Consequently, an increased
amount of training in surgical skills has to be
done with simulators (for example, latex
models of organs, laparoscopic boxes),
anaesthetised animals (for laparoscopic and
endovascular procedures), or computer gen›
erated virtual reality (for example, laparos›
copy, endoscopy).3 Such facilities must be
widely available to all trainees.
Finally, the assessment of operative skill
needs to become more objective and
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independent.4 Assessment methods (such as
the objective structured assessment of
technical skills or the Imperial College
surgical assessment device) are already
available. Detecting underperformance early
would allow further training and guidance.
We need to reappraise, reform, and modern›
ise surgical training rather than blame
Europe for cutting junior doctors’ working
hours.
Y C Chan specialist registrar in general surgery,
South›East Deanery
Department of Surgery, King’s College Hospital,
London SE5 9RS
ycchan88@hotmail.com
1 Pickersgill T. The European working time directive for
doctors in training. BMJ 2001;323:1266. (1 December.)
2 Taffinder N. Better surgical training in shorter hours. J R
Soc Med 1999;92:329›31.
3 Torkington J, Smith SG, Rees BI, Darzi A. The role of
simulation in surgical training. Ann R Coll Surg Engl
2000;82:88›94.
4 Darzi A, Datta V, Mackay S. The challenge of objective
assessment of surgical skill. Am J Surg 2001;181:484›6.
Improving outcomes in
depression
Integrated solutions should not be
provided at the expense of reduced
participation of statutory sector
Editor—An overview by experts in the field
reasoning for and recommending the better
quality and delivery of care to a substantial
population is greatly to be welcomed.1 We
need a person centred, whole system
approach, with medical management being
but a part of the best practice “prescription.”
Early intervention and active management
work for every other condition known to
man and prevent the long term complica›
tions of potentially recurrent or chronic ill
health, whether it be asthma, diabetes,
hypertension, or depression. The cerebral
dysfunction associated with depression
(which is far more than a mood disorder)
produces lost quality of life, disability,
comorbidity, and somatisation—all of which
cost the health, social, and employers’ budg›
ets billions of pounds a year and place a
huge burden of work on practitioners of pri›
mary healthcare and social care.
The voluntary and private sectors also
have a major part to play. However,
integrated solutions should not be provided
at the expense of reduced participation of
the statutory sector, simply to enable
government to keep taxation down or avoid
responsibility for service provision under
the guise of increasing the flexibility for local
solutions.
The key educational message must also
be that psychological issues themselves gen›
erate some 40% of consultations in general
practice and should be dealt with as a prior›
ity at the beginning, not as a door handle
exit strategy at the end. The national service
framework for mental health underpins all
the others and provides the template for the
generic issues and highest common factor
“doables” that weave through all of them,
from information and communication
strategies through to the necessity for attitu›
dinal and behavioural change. Learning
how to work more effectively together and
moving towards a culture in which, if we are
all agreed on something, then only one of us
needs to go to the meeting, would
contribute enormously to the mental well›
being of service providers, let alone users.
Introducing depression management
into general practitioners’ management
remit for chronic disease and their remu›
neration and commissioning system would
also help to improve standards of care for
this group of patients much more quickly.
This must happen under the contractual
arrangements of the new primary care
trusts, and when it does, as a service user, I
will be finally convinced that people are
genuinely committed to doing something
real, rather than rhetorical, about the care of
this now extremely common, and for many,
severe and enduring mental illness.
Chris Manning chief executive officer
Primary care Mental Health and Education
(PriMHE), The Old Stables, 2A Laurel Avenue,
Twickenham TW1 4JA
1 von Korff M, Goldberg D. Improving outcomes in depres›
sion. BMJ 2001;323:948›9. (27 October.)
Practice of medicine should carry health
warning
Editor—The two doctors who wrote about
their depressive illnesses should be
congratulated.1 2A few years ago admission
of mental ill health by a doctor would have
been unthinkable. A weight of evidence is,
however, accumulating, which shows that
the mental health of doctors is on average
worse than the general population’s.3
The reasons for this are complex but
include factors specific to the young people
who become doctors and to the job itself.
Qualitative research has shown that some
medical students are motivated to study
medicine as a partial response to uncon›
scious neurotic drives and unresolved
conflicts from childhood.4 I have met ill doc›
tors who have said that they entered the
profession to put right distress or illness that
occurred to them or members of their fam›
ily during their childhood. Qualification did
not resolve these emotional conflicts.
Doctors who have had mental ill health
may be more empathic with patients with a
similar illness, but empathic doctors are
more likely to have emotional fatigue later
in their careers. Doctors at greatest risk of
such fatigue (“burnout”) are those in general
practice, psychiatry, oncology, and general
medicine. High levels of self criticism, a per›
fectionist approach, and poor team working
are also associated with poor mental health
in doctors.5
The practice of good medicine is
intellectually and emotionally demanding,
and as the expectations of our patients,
managers and professional bodies increase
so do the pressures on doctors. It is no won›
der that doctors are breaking down or leav›
ing the profession prematurely. The practice
of medicine is fraught with dangers and
should carry a health warning for both
patients and doctors.
C J M Poole consultant occupational physician
Dudley Priority Health NHS Trust, Health Centre,
Cross Street, Dudley, DY1 1RN
jon.poole@dudleyph›tr.wmids.nhs.uk
1 Anonymous. Why am I crying? BMJ 2001;323:1010. (27
October.)
2 McKall K. An insider’s guide to depression. BMJ
2001;323:1011. (27 October.)
3 Williams S, Michie S, Pattani S. Improving the health of the
NHS workforce. London: Nuffield Trust, 1998.
4 Maxwell H. Clinical psychotherapy for health professionals.
London: Whurr, 2000.
5 Firth›Cozens J. Predicting stress in general practitioners:
10 year follow up postal survey. BMJ 1997;315:34›5.
The future of rehabilitation
Rehabilitation should be regarded as
scientific challenge
Editor—Greenwood’s editorial on the
future of rehabilitation is a welcome sign
that British neurologists have accepted
restorative neurology as part of their
discipline.1 But it suggests that their grasp of
what rehabilitation is, and their understand›
ing of the range of objectives that rehabilita›
tion medicine seeks to achieve, are still
uncertain.
For disabled people whose impairments
cannot be reversed, rehabilitation involves
processes that are clearly distinct from
biological recovery, including learning, the
acquisition of new skills, and the changing of
behaviour. This is the case for the many
non›neurological causes of impairment as
well as the neurological ones.
Greenwood suggests that neurologists
are far more disposed to accept published
evidence that rehabilitation works now that
they are able to view physical changes in the
brain that might be taking place concur›
rently with it. If this is true they are seriously
confusing two kinds of evidence.
Scientific study of the acquisition of skills
and of the processes that enhance or
obstruct it is potentially valuable in increas›
ing our understanding of the processes
involved and predicting how we might best
promote them. But the demonstration of
brain mechanisms at work is not proof that
rehabilitation has been achieved. Other and
different scientific approaches are necessary
for that. Furthermore, Greenwood makes no
mention of the influence that changes in a
person’s environment (especially the behav›
iour of others) can have on the overall
outcome of rehabilitation—the wellbeing
and social participation of the subject,
not simply the eradication of biological
impairments.
Finally, Greenwood’s carping at rehabili›
tation medicine as a discipline is surely
unjustified. He seems to think that four
months’ training in rehabilitation medicine
is ample to enable neurologists to practise it
on their patients but that one year’s training
in neurology is not nearly enough to allow
specialists in rehabilitation medicine to pro›
mote rehabilitation in those with neurologi›
cal disorders.
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The future of rehabilitation would look
brighter if health professionals saw it as a
scientific challenge in its own right to be met
by interdisciplinary collaboration rather
than as an opportunity for them to annexe
clinical territory from others as soon as bits
started to look interesting to them. Perhaps
more neurologists could be prevailed on to
attend meetings of the multidisciplinary
Society for Research in Rehabilitation.
There they could meet colleagues from the
other disciplines already expert in this area,
expand the old fashioned concepts of reha›
bilitation rehearsed in the editorial, and
make a contribution to much needed
progress in this important field.
Lindsay McLellan emeritus professor of rehabilitation
Health and Rehabilitation Research Unit, School of
Health Professions and Rehabilitation Sciences,
University of Southampton, Southampton
SO16 6YD
dlm@soton.ac.uk
1 Greenwood R. The future of rehabilitation. BMJ
2001;323:1082›3. (10 November.)
Specialist rehabilitation is best done by
those with skills in rehabilitation
Editor—Greenwood fails to address the title
of his editorial and dismisses the contribution
that physicians in rehabilitation medicine
have made to the development of specialist
rehabilitation in the United Kingdom over
the past 15 years.1 Restorative neurology has
exciting prospects, but patients will not
benefit without specialist rehabilitation by
physicians wholly engaged in the field. Physi›
cians in rehabilitation medicine spend four
years learning the principles and practice of
rehabilitation, as well as its delivery through
multiprofessional working. Twelve months in
neurological rehabilitation is obligatory, but
trainees intent on clinical practice spend fur›
ther time during their programme address›
ing all aspects.
What does the health service need from
its future rehabilitation professionals? Physi›
cians and surgeons should provide rehabili›
tation for their own patients where possible,
and it is thus desirable and appropriate that
trainees in neurology should learn about it.
This will teach them the basic principles but
will not equip them to care for people with
complex problems, who require a multipro›
fessional team to provide for them. The
NHS needs to develop rehabilitation at
primary care level for people living in the
community but also to provide access to
specialist facilities where appropriate.
New drug treatments may improve the
functioning of people disabled by neuro›
logical disease, but both their successful par›
ticipation in life and their wellbeing require
doctors who are interested in rehabilitation.
No apology should be made for this. When
health care is provided by overstretched cli›
nicians it is too easy to drop rehabilitation as
an activity as it requires a lot of time and
effort; mainstream specialty activities are
seen as more pressing.
Rehabilitation medicine was created for
this very reason, as rehabilitation was simply
not done in the past by neurologists,
rheumatologists, etc. Yes, let us hope for fur›
ther advances in restorative neurology. But
let us also see rehabilitation develop in both
primary and acute secondary care. It should
be complemented by specialist rehabilita›
tion delivered by appropriately trained
physicians—whether from rehabilitation
medicine or clinical neurology—who have
the time, skill, and resources, as well as the
commitment and motivation, for the subject.
The changes to dual accreditation in
neurology and rehabilitation medicine are
to be welcomed, but effective specialist reha›
bilitation is best done by those with
knowledge of and skills in rehabilitation
rather than wholly concentrated in the
underlying disease process. Let us address
the future rehabilitative needs of the patients
and not of the doctors.
Anthony B Ward consultant in rehabilitation
medicine
North Staffordshire Hospital, Stoke on Trent
ST6 7AG
anthony@bward2.freeserve.co.uk
1 Greenwood R. The future of rehabilitation. BMJ
2001;323:1082›3. (10 November.)
Risky drinking by both sexes
should be tackled
Editor—Having read Plant and Plant’s
letter on drinking by young British women,1
we present data on 12 361 men and 20 534
women aged 20›80 from the genetic
environmental nature of emotional states in
siblings (GENESiS) study. These data sug›
gest that it is not just drinking by young Brit›
ish women that gives cause for concern:
drinking by young British men does too.
The study is a questionnaire study based
in the United Kingdom and includes
measures on various mental health items as
well as measures of alcohol consumption.
Subjects were recruited in 1997›2000
through the Medical Research Council’s
general practice research framework. The
participating general practitioners identified
the names and addresses of all patients on
their registers aged 20›55, excluding those
with severe learning difficulties or psychotic
illness. Siblings of these initial patients aged
20›80 were also recruited to take part.
The data provide no evidence of
different trends developing in the drinking
careers of women and men, as reported by
Plant and Plant. In fact, the table shows that
a consistently greater percentage of men
than women drink at high risk levels (>51
units a week for men, >35 units a week for
women). It also shows a pronounced reduc›
tion in numbers reporting risky drinking
with increasing age.
Plant and Plant describe a sex difference
in the pattern of drinking such that men are
more likely to report heavy drinking in the
age group 35›54 but women are more likely
to do so in the age group 18›24. The GEN›
ESiS data show no such difference and indi›
cate that heavy drinking is common and a
cause for concern in both young men and
young women.
The percentage of alcohol consumed
non›sensibly (men > 4 units a day, women
> 3 units a day) and heavily (men > 8 units
a day, women > 6 units a day) was also
calculated. In both sexes 88›90% of alcohol
consumed by the 20›29 age group was con›
sumed non›sensibly and 40›48% was con›
sumed heavily, figures that are similar to
those in a recent report from the Depart›
ment of Health.2
It is thus vital that risky drinking by both
men and women should be addressed in
young adults. Tackling risky drinking behav›
iour in young people should be a key feature
of the long overdue alcohol strategy.
Richard Williamson research worker
Richard.Williamson@iop.kcl.ac.uk
Pak Sham professor
David Ball senior lecturer
Social, Genetic and Developmental Psychiatry
Research Centre, Institute of Psychiatry, King’s
College London, London SE5 8AF
1 Plant M, Plant M. Heavy drinking by young British women
gives cause for concern. BMJ 2001;323:1183. (17
November.)
2 Department of Health. Drinking: adults behaviour and
knowledge in 2000. London: DoH, 2001.
Time has come for mandatory
unit labelling
Editor—The editorial by Ferner and Cham›
bers illustrated both the difficulties inherent
in calculating the number of units con›
sumed and the dangers in excess alcohol
consumption.1 So what should we do?
Australia’s commonsense and research
based approach was to legislate for compul›
sory labelling of alcoholic beverages with
“standard drinks.” In the United Kingdom
we are at least six years behind Australia, and
only those drinks companies and retailers in
agreement with unit labelling are taking part
in a voluntary scheme launched in 1999.
Some companies could be praised for their
clear bold labelling, whereas others employ
tiny difficult to read symbols of dubious use.
We called for the government to
legislate for bold unit labelling on the front
of alcoholic drink containers and this has
now been supported by the Drug and Thera›
peutics Bulletin.2 3 A natural conclusion for
Ferner and Chambers would also be to call
for unit labelling.
After more than a decade of offering
health advice on alcohol in terms of units,
health professionals should end the confu›
sion. The BMA and the royal colleges should
Numbers (percentages) of all subjects drinking at high risk levels
Age (years)
Sex 20›24 25›29 30›34 35›39 40›44 45›49 50›54 55›59 60›64 65›69 70›74 >75
Male 39 (13) 93 (10) 86 (6) 80 (5) 97 (5) 74 (4) 87 (4) 61 (4) 7 (6) 1 (4) 0 0
Female 36 (6) 98 (5) 87 (3) 79 (3) 91 (3) 103 (4) 92 (3) 30 (1) 1 (1) 0 0 1 (13)
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be calling on the government to introduce
compulsory unit labelling.
Phil J Webster›Harrison general practitioner
Port View Surgery, Saltash PL12 4BU
pjwh@globalnet.co.uk
Andy G Barton coordinator
Plymouth and South Devon Research and
Development Support Unit, Plymouth
Postgraduate Medical School, Plymouth PL6 8BX
1 Ferner RE, Chambers J. Alcohol intake: measure for meas›
ure. BMJ 2001:323:1439›40. (22›29 December.)
2 Webster›Harrison PJ, Barton AG, Berton SM, Anderson
SD. General practitioners’ and practice nurses’ knowledge
of how much patients should and do drink. Br J Gen Pract
2001;51:218›20.
3 Getting tight on units of alcohol. Drug Ther Bull
2001;39:95.
Child outpatient
non›attendance may indicate
welfare concerns
Editor—Much effort has been put into
reducing the high rates of non›attendance at
outpatient clinics.1 2 Currently there is a
drive to improve the quality of outpatient
services, which in itself will improve attend›
ance rates. The laudable recommendations
of the Clinical Standard Advisory Group
approach the problem from a health
perspective.3 Sharp and Hamilton’s editorial
rehearses some of these strategies and high›
lights the magnitude of the problem in
deprived populations.4 Social circumstances
are a major influence on health, and we
explored this in an audit of outpatient
paediatric non›attenders.
We performed a retrospective audit of
all paediatric outpatients attending a district
general hospital in a deprived area of
London over six months from January to
June 2000. Of 2183 appointments, 685 were
missed. Altogether, 589 were for children
living in the local borough. Of these, 218
were for patients known on the social
services database (157 were themselves on
the database, while in the remaining 61
cases other family members were listed). Of
the 157 patients, 38 were listed on the child
protection index, of whom eight were on the
current child protection register.
Thus we found that one third of the out›
patient non›attenders were known to social
services. Our audit illustrates why we must
consider non›attendance within the wider
social context and the importance of close
liaison with social services. Medical staff
must recognise non›attendance as a possible
indicator of child welfare concerns and
make contact with social services. This audit
shows that good interagency working
(encouraged by the Health Act 1999, the
NHS Plan, and the Department of Health) is
justifiably a high priority.
Mando Watson consultant paediatrician
St Mary’s Hospital, London W2 1NY
Mando.Watson@st›marys.nhs.uk
Martin Forshaw team manager
Children and Families, Social Work Department,
West Middlesex Hospital, Isleworth, Middlesex
TW7 6AF
1 Stone CA, Palmer JH, Saxby PJ, Devaraj VS. Reducing
non›attendance at outpatient clinics. J R Soc Med
1999;92:114›8.
2 Gatrad AR. A completed audit to reduce hospital
outpatients non›attendance rates. Arch Dis Child
2000;82:59›61.
3 Dodd K, Newton J. Outpatient services for children. Arch
Dis Child 2001;84:283›5.
4 Sharp D, Hamilton W. Non›attendance at general practices
and outpatient clinics. BMJ 2001;323:1081›2. (10 Novem›
ber.)
Hospitals must not be closed
without considering all factors
Editor—The article by Lock, the former
member of parliament for Kidderminster,
who is upset about losing his parliamentary
seat having failed to convince his constituents
that they did not need their local hospital, is
interesting.1 It shows the chasm that has
opened up between politicians and the
general public and the tight compartments
into which the government confines decision
making, despite the promise of joined up
government. The only consideration men›
tioned by Lock is medical safety in Kidder›
minster Hospital, and the only people he
seems to have consulted are doctors, and yet
he remains confident that he is right and
28 000 voters in Kidderminster are wrong.
What about other relevant factors? Can
the alternative hospital handle the increased
load? Is it accessible? Are any bottlenecks
likely to separate the people of Kiddermin›
ster from their accident and emergency
cover? Can the ambulance service handle
the increased load and guarantee to deliver
patients on time? Are essential staff likely to
be retained within the NHS? Is the
population in the catchment area increasing
or decreasing? Is there potential for major
disasters in the area? Can these be handled
once the target hospital is closed? There is
no medical safety in having the best manned
and equipped hospital in the country if it
cannot do the job.
The Kidderminster experience is almost
a repeat of what has happened in Gosport.
The main differences are that our local hos›
pital, the Royal Hospital Haslar, is also the
United Kingdom’s last military hospital, and
our member of parliament listened to his
constituents and is leading the “Save Haslar”
campaign. As in Kidderminster, the public
consultation revealed little common ground
between platform and public, and as usual
the public proved to be right. Lack of capac›
ity to cope with additional patients at neigh›
bouring hospitals has forced the reopening
of much of Haslar Hospital. This will
become even more important as a massive
house building programme attracts thou›
sands more people into the catchment area.
The accident and emergency department
has not yet been restored, but everyone
knows that the current provision is inad›
equate. The prospect of a seriously ill patient
from Gosport reaching accident and emer›
gency in time, along the highly congested
single lane road, is highly speculative.
Politicians must start listening to the
public, and all relevant factors must be fully
considered before such important decisions
as hospital closures are taken. The closure of
Haslar, which has caused so much anxiety
and distress in this district, was decided uni›
laterally by the Ministry of Defence.
John Parry retired
20 Crescent Road, Alverstoke, Gosport, Hampshire
PO12 2DH
1 Lock D. Stuck in the middle? BMJ 2001;323:1195. (17
November.)
Death after inserting Hickman
line was probably avoidable
Editor—The death of a 15 year old girl in
1998 due to a complication of inserting a
Hickman line, and the ensuing court case in
December last year, highlight the consider›
able morbidity and occasional mortality
associated with central venous access. In one
year alone the Scottish audit of surgical
mortality identified four deaths directly
attributable to insertion of a venous line. A
greater number of patients have their
serious medical conditions further compli›
cated by iatrogenic pneumothorax; the true
extent of these problems is unknown.
For the past 15 years this hospital has
provided a dedicated weekly operation list for
the insertion of central lines, placing over 250
each year and often dealing with highly com›
plex situations in patients who have had
many previous lines and patients who are
referred from other hospitals. We have not
had one death related to insertion of a line,
and pneumothorax is virtually unknown. We
use local anaesthesia, ultrasound scanning to
identify the right internal jugular vein in most
cases, and a closed “peel cath” technique.
Why did this complication occur, and
can it be eradicated? I believe that a major
factor is the design of the equipment, and in
particular the length of the introducing dila›
tor and peel cath. The internal jugular vein
in the neck is always within easy reach of a
standard green needle, which typically
measures 3.5 cm in length. However, the
typical length of the introducing dilator pro›
vided by most manufacturers for line
insertion is almost 20 cm, so when it is
placed fully within the vein in the neck as
required its tip is lying within the heart.
A dilator of this length is rarely needed.
If we could persuade manufacturers to
reduce its length to 10 cm in standard packs
then the complication from which this
patient died simply could not occur. I drew
this fact to the attention of the Scottish
Home and Health Department when the
case was first reported, but it declined to take
the matter any further.
S J Nixon consultant surgeon
Western General Hospital, Edinburgh EH4 2XU
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